NOVEN REPORTS POSITIVE PHASE 2 RESULTS FOR MESAFEM™ NON-HORMONAL THERAPY FOR VASOMOTOR SYMPTOMS Miami, FL – July 14, 2009 – Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced positive top-line results from - Line 2 - Document - PDFSEARCH.IO

First Page	Meta Content
	NOVEN REPORTS POSITIVE PHASE 2 RESULTS FOR MESAFEM™ NON-HORMONAL THERAPY FOR VASOMOTOR SYMPTOMS Miami, FL – July 14, 2009 – Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced positive top-line results from Add to Reading List Document Date: 2013-06-27 13:50:45 Open Document File Size: 235,85 KB Share Result on Facebook

NOVEN REPORTS POSITIVE PHASE 2 RESULTS FOR MESAFEM™ NON-HORMONAL THERAPY FOR VASOMOTOR SYMPTOMS Miami, FL – July 14, 2009 – Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced positive top-line results from Add to Reading List